2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 21.192 | 22.594 | 26.414 | 27.278 | 32.093 | 34.252 | 43.294 | 35.000 | 40.137 | 46.964 |
Total Income - EUR | 21.192 | 22.597 | 26.415 | 27.279 | 32.093 | 34.253 | 43.294 | 35.000 | 40.138 | 46.964 |
Total Expenses - EUR | 18.996 | 22.600 | 25.528 | 27.401 | 31.204 | 33.603 | 39.222 | 34.273 | 39.207 | 44.158 |
Gross Profit/Loss - EUR | 2.196 | -3 | 887 | -123 | 889 | 649 | 4.072 | 727 | 931 | 2.806 |
Net Profit/Loss - EUR | 1.560 | -681 | 623 | -396 | 568 | 307 | 3.639 | 419 | 674 | 2.381 |
Employees | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biofarma-Vet Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 753 | 1.061 | 981 | 1.293 | 1.052 | 1.468 | 1.073 | 760 | 517 | 453 |
Current Assets | 1.697 | 1.975 | 2.368 | 2.106 | 2.496 | 2.785 | 5.103 | 6.639 | 6.634 | 9.048 |
Inventories | 1.661 | 1.911 | 2.308 | 2.016 | 2.346 | 2.510 | 3.986 | 5.430 | 5.443 | 6.882 |
Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 |
Cash | 37 | 64 | 60 | 89 | 150 | 274 | 1.117 | 1.203 | 1.191 | 2.166 |
Shareholders Funds | 1.254 | 584 | 1.200 | 785 | 1.338 | 1.619 | 5.228 | 5.530 | 6.221 | 8.583 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 1.197 | 2.452 | 2.148 | 2.614 | 2.210 | 2.634 | 948 | 1.869 | 930 | 918 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
7500
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Biofarma-Vet Srl